Emily Reeve

8.8k total citations · 2 hit papers
129 papers, 5.5k citations indexed

About

Emily Reeve is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Family Practice. According to data from OpenAlex, Emily Reeve has authored 129 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Geriatrics and Gerontology, 63 papers in Economics and Econometrics and 33 papers in Family Practice. Recurrent topics in Emily Reeve's work include Pharmaceutical Practices and Patient Outcomes (95 papers), Health Systems, Economic Evaluations, Quality of Life (60 papers) and Medication Adherence and Compliance (33 papers). Emily Reeve is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (95 papers), Health Systems, Economic Evaluations, Quality of Life (60 papers) and Medication Adherence and Compliance (33 papers). Emily Reeve collaborates with scholars based in Australia, Canada and United States. Emily Reeve's co-authors include Sarah N. Hilmer, Danijela Gnjidic, Michael D. Wiese, Sepehr Shakib, Michael S. Roberts, Ivanka Hendrix, Janet C. Long, Jesse Jansen, Lee‐Fay Low and Ian Scott and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emily Reeve

118 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reducing Inappropriate Polypharmacy

2015 1.0k citations Ian Scott, Sarah N. Hilmer et al. profile →
A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice.

2015 478 citations Emily Reeve, Danijela Gnjidic et al. British Journal of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Reeve Australia	35	4.4k	2.7k	1.5k	908	735	129	5.5k
Stephen Byrne Ireland	37	4.6k 1.0×	2.4k 0.9×	1.3k 0.9×	1.0k 1.1×	981 1.3×	156	6.3k
Danijela Gnjidic Australia	39	5.0k 1.1×	2.8k 1.1×	1.1k 0.7×	791 0.9×	1.4k 2.0×	173	6.9k
Paul Gallagher Ireland	34	5.3k 1.2×	2.7k 1.0×	1.5k 1.0×	638 0.7×	1.0k 1.4×	70	6.6k
Cristín Ryan Ireland	35	6.1k 1.4×	3.1k 1.2×	1.9k 1.3×	1.0k 1.1×	1.3k 1.7×	130	7.5k
Kristina Johnell Sweden	43	3.4k 0.8×	1.7k 0.7×	1.0k 0.7×	740 0.8×	1.3k 1.7×	184	6.4k
Denis O’Mahony Ireland	47	7.4k 1.7×	3.9k 1.5×	2.1k 1.4×	1.1k 1.2×	1.7k 2.3×	201	10.4k
Donna M. Fick United States	33	2.5k 0.6×	1.1k 0.4×	695 0.5×	1.2k 1.4×	646 0.9×	132	6.2k
Mark H. Beers United States	28	6.4k 1.5×	3.1k 1.2×	1.8k 1.2×	1.4k 1.6×	1.2k 1.6×	53	8.6k
Emily Hajjar United States	16	2.4k 0.6×	1.2k 0.5×	751 0.5×	324 0.4×	682 0.9×	29	3.5k
Anne Spinewine Belgium	27	2.4k 0.5×	1.2k 0.4×	717 0.5×	486 0.5×	497 0.7×	120	3.3k

Countries citing papers authored by Emily Reeve

Since Specialization

Citations

This map shows the geographic impact of Emily Reeve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Reeve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Reeve more than expected).

Fields of papers citing papers by Emily Reeve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Reeve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Reeve. The network helps show where Emily Reeve may publish in the future.

Co-authorship network of co-authors of Emily Reeve

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Reeve. A scholar is included among the top collaborators of Emily Reeve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Reeve. Emily Reeve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bayliss, Elizabeth A., Glenn K. Goodrich, Courtney R. Kraus, et al.. (2025). Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiology and Drug Safety. 34(4). e70142–e70142. 2 indexed citations

Reeve, Emily, et al.. (2025). Deprescribing Benzodiazepine Receptor Agonists in Older Adults and People With Cognitive Impairment: A Systematic Review. Journal of the American Geriatrics Society. 73(9). 2905–2913.

Ilomäki, Jenni, et al.. (2025). Barriers and enablers to deprescribing for people living with cystic fibrosis: Multidisciplinary perspectives. Respiratory Medicine. 242. 108091–108091.

Reeve, Emily, Ashley M. Hopkins, Nagham Ailabouni, et al.. (2024). Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis. Arthritis Care & Research. 76(6). 871–881. 1 indexed citations

Reeve, Emily, et al.. (2024). Deprescribing antihypertensive drugs in frail older adults. Australian Prescriber. 47(3). 85–90. 1 indexed citations

Bero, Lisa, Fiona Blyth, Jason N. Doctor, et al.. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. The Medical Journal of Australia. 219(2). 80–89. 25 indexed citations

Rusu, Adriana, Andreea Farcaș, Dan L. Dumitraşcu, et al.. (2023). Translation, cultural adaptation and validation of the revised patients’ attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults. Research in Social and Administrative Pharmacy. 19(11). 1471–1479.

Reeve, Emily, R. Colton Bramwell, Laura Villasana, et al.. (2022). Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice. Journal of Cerebral Blood Flow & Metabolism. 43(2). 281–295. 6 indexed citations

Fulda, Kimberly G., et al.. (2022). Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety. Expert Opinion on Drug Safety. 21(11). 1357–1364. 12 indexed citations

10.

O’Donnell, Lisa Kouladjian, et al.. (2021). Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians. Internal Medicine Journal. 51(1). 111–115. 7 indexed citations

11.

Isenor, Jennifer E., Emily Reeve, Anne Marie Whelan, et al.. (2021). Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs. Research in Social and Administrative Pharmacy. 18(8). 3350–3357. 17 indexed citations

12.

Reeve, Emily. (2020). Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. Journal of Pharmacy Practice and Research. 50(1). 98–107. 70 indexed citations

13.

O’Donnell, Lisa Kouladjian, Danijela Gnjidic, Mouna Sawan, et al.. (2020). Impact of the Goal‐directed Medication Review Electronic Decision Support System on Drug Burden Index: A cluster‐randomised clinical trial in primary care. British Journal of Clinical Pharmacology. 87(3). 1499–1511. 28 indexed citations

14.

Reeve, Emily, Lee‐Fay Low, & Sarah N. Hilmer. (2019). Attitudes of Older Adults and Caregivers in Australia toward Deprescribing. Journal of the American Geriatrics Society. 67(6). 1204–1210. 73 indexed citations

15.

Reeve, Emily, et al.. (2018). Development and pilot testing of the revised Patients’ Attitudes Towards Deprescribing questionnaire for people with cognitive impairment. Australasian Journal on Ageing. 37(4). E150–E154. 31 indexed citations

16.

Reeve, Emily, Shanna Trenaman, Kenneth Rockwood, & Sarah N. Hilmer. (2017). Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opinion on Drug Metabolism & Toxicology. 13(6). 651–668. 53 indexed citations

17.

Reeve, Emily, Petra Denig, Sarah N. Hilmer, & Ruud ter Meulen. (2016). The Ethics of Deprescribing in Older Adults. Journal of Bioethical Inquiry. 13(4). 581–590. 33 indexed citations

18.

Reeve, Emily, Lee‐Fay Low, Sepehr Shakib, & Sarah N. Hilmer. (2016). Development and Validation of the Revised Patients’ Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers. Drugs & Aging. 33(12). 913–928. 144 indexed citations

19.

Waddington, C. H., Charlotte Auerbach, J. R. S. Fincham, et al.. (1969). GRH volume 14 issue 1 Cover and Front matter. Genetics Research. 14(1). f1–f6. 1 indexed citations

20.

Waddington, C. H., Charlotte Auerbach, David Lewis, et al.. (1967). GRH volume 9 issue 2 Cover and Front matter. Genetics Research. 9(2). f1–f5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact